title: Novel investigational approaches for inhibiting angiogenesis in recurrent glioblastoma.
authors.affiliation: aMemorial Sloan-Kettering Cancer Center, New York, New York, USA bCancer Clinical Trials Unit, Beaumont Hospital, Dublin, Ireland.
authors.forename: Richard M
authors.initials: RM
authors.lastname: Bambury
authors.forename: Patrick G
authors.initials: PG
authors.lastname: Morris
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy*; D005260:Female; D005910:Glioma / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local; D009536:Niacinamide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010671:Phenylurea Compounds / Q000627:therapeutic use*; D000077157:Sorafenib
chemical_list: D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D009536:Niacinamide; D000077157:Sorafenib